ZITUVIMET XR 50-1,000 MG TABLET

sitagliptin and metformin hydrochloride
$5.0263per EA

Strength

1000; 50 mg/1; mg/1

NDC

70710180506

Classification

Brand

Dosage Form

TABLET, FILM COATED, EXTENDED RELEASE

Route

ORAL

Last Updated

4/22/2026

Approval Type

New Drug (NDA)

FDA Application

NDA216778

On Market Since

10/31/2024

Pharmacological Classes

Biguanide
Biguanides
Dipeptidyl Peptidase 4 Inhibitor
Dipeptidyl Peptidase 4 Inhibitors

Price History

1W

0.0%

1M

-0.1%

3M

-0.1%

6M

-0.2%

1Y

-0.7%

3Y

N/A

5Y

N/A

All

-0.7%